Oxytocin for Hypermobile Ehlers-Danlos Syndrome

PHASE1,PHASE2

Phase

TERMINATED

Status

Enrollment

OTHER

Sponsor class

Stopped Study team has decided to close the trial (NCT05405257) due problems with patient recruitment and enrollment efforts. To date, only one patient completed both arms.

Conditions

Hypermobile Ehlers-Danlos Syndrome
Pain Assessment

Interventions

DRUG: Oxytocin
OTHER: Placebo

Sponsor

Baylor College of Medicine